Menu Close

Articles on Intellectual property

Displaying 1 - 20 of 111 articles

Until the late 19th century, patenting medicines was considered by some as controversial and even unethical. S. Vannini/De Agostini Editorial via Getty Images

The US drug industry used to oppose patents – what changed?

The pharmaceutical industry overall has been deeply opposed to waiving COVID-19 vaccine patents, but a historian of the industry explains that drug companies once opposed patents altogether.
Anita Anand, Canada’s minister of public services and procurement, opens a box with some of the first 500,000 of the two million AstraZeneca COVID-19 vaccine doses that Canada secured last March through a deal with the Serum Institute of India. THE CANADIAN PRESS/Carlos Osorio - POOL

Canada is virtue signalling while waffling on global access to COVID-19 vaccines

Despite some public virtue signalling, the Canadian government is not doing all it can to improve global access to COVID-19 vaccines. Canada has yet to announce its position on the WTO patent waiver.
The US has agreed to ‘free the vaccine’, but will it work? Allison Bailey / Alamy Stock Photo

US-backed vaccine patent waiver: pros and cons explained

It’s not clear whether the TRIPS agreement is what’s getting in the way of vaccine supply, and waiving intellectual property rights may stifle future innovation.
Prime Minister Justin Trudeau, right, speaks with scientist Krishnaraj Tiwari at the National Research Council of Canada (NRC) Royalmount Human Health Therapeutics Research Centre facility in Montreal, Aug 31, 2020. THE CANADIAN PRESS/Graham Hughes

How Canada can become a global leader in health innovation during the COVID-19 pandemic and beyond

To continue the fast-paced collaborative research and innovation we have seen during the pandemic, here are five ways universities can support health research that responds to societal needs.

Top contributors

More